Genprex, Inc.
GNPX institutional ownership changes in Q2 2026: 8 institutions opened or added positions, 3 trimmed or exited. GNPX (Genprex, Inc.) is held by 15 institutional investors as of Q2 2026. Top institutional shareholders: Vanguard Fiduciary Trust Co. ($40,536), HRT Financial LP ($37,000), Geode Capital Management, LLC ($31,319). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Apr 15, 2026 · Activists May 11, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
New | 78,104 | $40,536 | 0.0% | -79.77% | 31 | |
New | 72,061 | $37,000 | 0.0% | -79.77% | 28 | |
Increased | 60,348(+80.8%) | $31,319 | 0.0% | -91.48% | 21 | |
Increased | 36,350(+510.9%) | $18,866 | 0.0% | -85.62% | 20 | |
New | 20,885 | $10,839 | 0.0% | -79.77% | 24 | |
Increased | 4,489(+4488x) | $2,330 | 0.0% | -79.78% | 13 | |
New | 1,578 | $819 | 0.0% | -79.77% | 17 | |
Decreased | 1,208(-42.6%) | $597 | 0.0% | -94.10% | 0 | |
Unchanged | 188 | $98 | 0.0% | -94.00% | 0 | |
Decreased | 82(-64.7%) | $41 | 0.0% | -94.00% | 0 | |
Increased | 23(+666.7%) | $12 | 0.0% | -84.55% | 12 | |
Unchanged | 6 | $3 | 0.0% | -94.00% | 0 | |
Unchanged | 2 | $1 | 0.0% | -94.00% | 0 | |
Unchanged | 1 | $1 | 0.0% | -94.00% | 0 | |
Unchanged | 1 | $1 | 0.0% | -94.00% | 0 | |
Exited | 0(-100.0%) | $3,691 | 0.0% | -71.32% | 0 |
| Insider | Trade | Traded |
|---|---|---|
| LONGNECKER BRENT M | Sell $12.3 | |
| LONGNECKER BRENT M | Sell $9.84 | |
| Berger Mark Stanley | Tax 7K sh | |
| Confer Ryan M. | Tax 9K sh | |
| Moreno Toscano Jose Antonio | Vest 9K sh | |
| Berger Mark Stanley | Vest 29K sh | |
| Wilson William R Jr. | Vest 9K sh | |
| Confer Ryan M. | Vest 45K sh | |
| LONGNECKER BRENT M | Vest 9K sh | |
| Confer Ryan M. | Tax 6K sh |
| Filer | Stake | Filed |
|---|---|---|
| Ayrton Capital LLC | 2.7% | |
| Mitchell P. Kopin | 5.0% |
GNPXGenprex, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about GNPX
Who owns GNPX?
15 institutional investors held GNPX on June 30, 2026, led by Vanguard Fiduciary Trust Co. ($40,536), HRT Financial LP ($37,000) and Geode Capital Management, LLC ($31,319).
How many hedge funds hold GNPX?
15 institutional investors reported GNPX in their 13F filings for the quarter ended June 30, 2026, $142,463 in all. One of them is rated Elite.
Are institutions buying or selling GNPX?
Buying, on balance. In Q2 2026, 8 institutions opened or added to positions in GNPX and 3 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer